Comments
SP Accure Labs, a Hyderabad-based pharma company, has launched an alternative drug Amphotericin-B-Emulation for treatment of Mucormycosis, the fungal infection better known as black fungus.
The growing incidence of black fungus infection is the latest health worry for the nation grappling with the second wave of Covid-19.
This new drug will be offered in the market within a week at ₹5,400 per unit.
P Girish Bhat, Managing Director, Medihauxe Pharma said “Currently we have 10,000 vials of the medicine in stock which is sufficient to treat around 1,000 patients. Medihauxe has been authorized to distribute this newly launched drug in the market in Telangana. We have necessary infrastructure including warehouse with cold chain facilities.”
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.